TROPONIN T (TNT) IS A SUBUNIT of the troponin complex in striated muscle cells, which interacts with troponin I (TnI), troponin C (TnC), and tropomyosin in the actin thin-filament-based Ca 2ϩ regulatory system (9) . The polypeptide chain of vertebrate TnT isoforms contains 233-305 amino acids. The COOH-terminal and middle regions of TnT bear the binding sites for TnI, TnC, and tropomyosin (27) and are highly conserved among cardiac, slow, and fast muscle TnTs and across species (18) . In contrast, the NH 2 -terminal region of TnT is hypervariable and confers the size and charge differences between TnT isoforms (18) . The NH 2 -terminal region of TnT does not bind any known myofilament proteins and may be proteolytically cleaved by -calpain as a functional adaptation to myocardial stress conditions (33) . The NH 2 -terminal truncated cardiac TnT remains association with the myofilament and sustains the contraction of cardiac muscle (7) .
Despite being an abundant myofilament protein, TnT has a relatively short half-life (3-4 days) in muscle cells (23) . Overexpression of TnT in cardiac muscle of transgenic mice does not increase TnT stoichiometry, but effectively replaces the endogenous cardiac TnT (3, 14) . Consistently with a rapid turnover of extra TnT, nonmyofilament-incorporated TnT or TnT fragment is rapidly degraded in myocytes (31) and in the muscle of Amish nemaline myopathy patients, in which a nonsense mutation of Glu 180 in exon 11 of slow skeletal muscle TnT results in a COOH-terminal truncation (15) . Therefore, the fast turnover rate of TnT reflects a high capacity of synthesis, as well as an effective proteolytic removal of surplus or damaged proteins. The excessive synthesis for an effective replacement of damaged TnT in muscle cells is plausible for the maintenance of structural integrity and function of the highly organized contractile machinery in striated muscle cells. On the other hand, the very rapid and near-complete removal (31) of nonmyofilament-associated TnT or TnT fragments may imply another critical necessity in maintaining normal cellular functions.
Experimental data have suggested a harmfulness of nonmyofilament-associated TnT and TnT fragments to cells. Despite the fact that we could readily establish stable transfected C 2 C 12 cell lines for a TnT promoter-directed, differentiation-dependent expression of exogenous TnT (31) , repeated experiments using the same procedure and conditions failed to establish even a single stable transfected clone for unregulated viral promoter-driven expression of intact TnT or TnT fragment in undifferentiated myoblasts and nonmuscle eukaryotic cells (unpublished results). For the difference in the presence or absence of myofibrils in differentiated muscle cells and undifferentiated myoblasts or nonmuscle cells, this observation suggests cytotoxicity of nonmyofilament-associated TnT or TnT fragments.
Massive releases of TnT or TnT fragments from myofilaments occur in acute myocardial infarction (21) , toxic myocardial injury (26) , and skeletal muscle injury (1) . If the peak level of free cytosolic TnT or TnT fragments exceeds the protective capacity of the proteolytic degradation in the muscle cell, it may result in toxic effects. The cytotoxicity of TnT fragments released from myofilaments may be correlated with the observation that activation of caspase-3, a signaling molecule in the pathways that induces apoptosis in various cell types, in cardiomyocytes, cleaves cardiac TnT (5), resulting in a decreased binding to tropomyosin (2) to cause disassociation of TnT from myofilaments. Adult cardiomyocytes have lost the ability to regenerate in ischemic heart disease and other types of myocardial injuries, which is an underlying mechanism for the development of cardiomyopathy and heart failure (22) . Therefore, it is of clinical importance to understand the potential effect of TnT fragments released from myofilaments on inducing apoptotic cell death, which may play a pathogenic role in cell death in acute myocardial infarction and in heart failure due to chronic losses of cardiomyocytes.
In the present study, we examined the cytotoxicity of different regions of the TnT polypeptide chain using transfective expression in cultured cells in the absence of neurohumoral and hemodynamic influences. The results demonstrated that the conserved COOH-terminal and middle fragments of TnT were highly cytotoxic through inducing apoptosis, whereas the NH 2 -terminal variable region was not. The data suggest that the apoptotic effect of nonmyofilament-associated TnT fragments may be a potential cause of cell death in myocardial injury and diseases.
MATERIALS AND METHODS
Construction of cDNA templates encoding representative fragments of TnT. The TnT polypeptide chain can be dissected into three structural domains that have been extensively studied for functions in the Ca 2ϩ regulation of muscle contraction: the conserved COOHterminal and middle regions, and the hypervariable NH 2-terminal region (Fig. 1A) (18, 27) . Therefore, we examined the potential cytotoxicity of TnT in engineered fragments representing the three regions. A COOH-terminal truncated slow TnT found in the Amish nemaline myopathy (31) and intact cardiac TnT were also examined for comparisons (Fig. 1B) .
Using a cDNA encoding intact mouse slow skeletal muscle TnT, cloned in pAED4 plasmid (16) , as template, two truncated cDNAs encoding the middle and COOH-terminal regions of TnT were constructed using polymerase chain reaction (PCR) mutagenesis. Outlined in Fig. 1C , an oligonucleotide primer was designed corresponding to the region flanking amino acids 154 -160 (MsTnT-M157F: CTGTCCCATATGGGAGCTCAT), in which an NdeI restriction enzyme site (underlined) was integrated with an endogenous Met codon ATG (bold) that was used as the translational initiation codon for the expression of the COOH-terminal T2 region (amino acids Met 157-Lys262). MsTnT-M157F was paired with a reverse primer pET-R in the vector sequence for PCR to amplify the T2 coding region. After modification at the ends by NdeI and EcoRI digestions, the MsTnT-T2 cDNA was unidirectionally inserted into pAED4 expression plasmid precut by the same restriction enzymes.
cDNA template encoding the middle region of mouse slow TnT (amino acids Pro 52-Leu154, MsTnT51met-154) was constructed by PCR using a forward primer designed corresponding to the region encoding amino acids 49 -55 (MsTnT-NDF: TCCTCATATGCCCCCGAA-GAT), which contains an artificial translational initiation Met codon ATG (bold) and an NdeI cloning site (underlined) and a reverse primer corresponding to the coding sequence for amino acids 152-159 (TnT-Ter2: AGGCACCCATGGACTACAGAGCCTT), which contains an artificial translational termination codon TAG (the antisense bases are in bold) and an NcoI cloning site (underlined). The PCR product was modified at the ends by NdeI and NcoI digestions and cloned into NdeI-EcoRI-cut pAED4 expression plasmid by two-step ligations, in which the ligation of NdeI sticky ends was followed by Klenow polymerase fill-in of the NcoI and EcoRI ends and subsequent blunt-end ligation.
A cDNA encoding full-length adult human cardiac TnT (HcTnT) was cloned by reverse transcription-coupled PCR (RT-PCR) from anonymous human cardiac mRNA using a method similar to that described previously for the cloning of cat, dog, and guinea pig cardiac TnT cDNAs (3). This investigation was determined to be exempted research by the Evanston Northwestern Healthcare Institutional Review Board.
A cDNA fragment was constructed using PCR to encode the NH 2-terminal variable region of TnT (amino acids 1-68 of HcTnT, HcTnT-N68). A reverse primer was designed corresponding to the region encoding amino acids 66-73 of adult HcTnT (HcTnT-68T: GTTGGAATTCAACTACCTGGGCTT), which contains an artificial translational termination codon TAG (the antisense bases are in bold) and an EcoRI cloning site (underlined). Using the full-length HcTnT cDNA template, PCR was carried out with HcTnT-68T primer and a degenerated forward primer (cTnT-E2F: CACATATGTCK-GACVYVGARGARG WGGTGG) flanking the natural translational initiation codon (bolded) in cardiac TnT of multiple mammalian species, which contains an added NdeI cloning site (underlined). The PCR product was modified at the ends with NdeI and EcoRI digestions and unidirectionally cloned into pAED4 plasmid precut with the same restriction enzymes.
A cDNA encoding COOH-terminal truncated mouse slow TnT (MsTnT was previously constructed in pAED4 vector (31) .
The five recombinant plasmids cloned in pAED4 (Fig. 1C ) were sequenced to verify the modifications and authenticity of cDNA inserts. The construction of representative TnT fragments was further confirmed by protein expression in transformed BL21(DE3)pLysS E. coli cells, as described previously (31) .
SDS-polyacrylamide gel electrophoresis and Western blotting. Protein samples were homogenized in SDS-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer containing 2% SDS and heated at 80°C for 5 min. Using a Bio-Rad mini-gel system, as previously described (31), intact HcTnT and MsTnT were resolved on 14% SDS-PAGE gel with an acrylamide-bisacrylamide of 180:1, and the HcTnT-N68, MsTnT 51met-154, and MsTnT-T2 fragments were resolved on 15% SDS-PAGE with an acrylamide-bisacrylamide of 29:1.
Duplicate gels were processed for Western blotting using sitespecific anti-TnT monoclonal antibodies (MAb) to verify the specific TnT fragments. Intact HcTnT and MsTnT 1-179 fragment were detected by MAb CT3 (16) . To identify the MsTnT-T2 fragment, a mouse MAb 1G9 (IgM) against an epitope in the COOH-terminal region was generated by hybridoma technology through a short-term immunization, with HcTnT purified from E. coli expression, as described previously (2) . The standard methods for hybridoma fusion and subcloning were described previously (17) . The middle fragment of TnT (MsTnT 51met-154) was identified using MAb 2C8 against a middle region epitope (15, 33) . For the identification of the NH2-terminal fragment of cardiac TnT, a mouse hybridoma MAb 3G7 (IgG1) was generated as above, using immunization with HcTnT-N68 protein expressed in E. coli and purified by ammonium sulfate precipitation and anion-exchange chromatography.
Western transfers for intact HcTnT and the MsTnT-T2, MsTnT 51met-154, and MsTnT 1-179 fragments using a Bio-Rad Laboratory semidry electrotransfer apparatus was done using standard conditions (31) . Blotting of the small and highly acidic HcTnT-N68 fragment (Table  1) was carried out using polyvinylidene difluoride membrane of 0.2-m pore size with much reduced current and time (5 mA/cm 2 for 6 min). To strengthen the blotting of N68 to the membrane, the blotted membrane was fixed with 0.1% glutaraldehyde in Tris-buffered saline (150 mM NaCl, 50 mM Tris ⅐ HCl, pH 7.5) containing 0.05% Tween 20 for 30 min (6).
The blotted membranes were blocked with 1% bovine serum albumin in Tris-buffered saline and incubated with the specific MAbs diluted in Tris-buffered saline containing 0.1% bovine serum albumin. The subsequent washes, incubation with alkaline phosphatase-labeled anti-mouse IgG second antibodies (Santa Cruz Biotechnology), and 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium substrate reaction were carried out, as described previously (31) .
Construction of pTracer bicistronic mammalian expression vectors. To transfectively express the TnT constructs in mammalian cells and investigate their cytotoxicity in the absence of myofilaments, we subcloned the cDNA inserts in mammalian expression plasmid vector pTracer (Invitrogen) (Fig. 1D ). In addition to expressing the cDNA insert under a SV40 promoter, pTracer plasmid contains a separate transcriptional unit encoding green fluorescence protein (GFP) under a cytomegalovirus promoter. Therefore, the TnT fragment-expressing cells can be traced under fluorescence microscope by the coexpression of GFP.
During the subcloning, the cDNA inserts encoding intact HcTnT, MsTnT 1-179, HcTnT-N68, MsTnT51met-154 and MsTnT-T2 were isolated from the recombinant pAED4 plasmids as NdeIEcoRI fragments. The pTracer vector DNA was cut by AflII-EcoRI. After ligation of the compatible EcoRI ends, Klenow polymerase fill-in and blunt-end ligation was followed to join the NdeI and AflII ends. The recombinant pTracer plasmid clones were screened by PCR, and the positive clones were verified by expression of Number of amino acids, molecular weight, and isoelectric point of the troponin T (TnT) proteins were calculated from sequences (GenBank/EBI Data Bank accession numbers: human cardiac TnT, NM_001001430; mouse slow TnT, AF020946).
GFP and TnT fragments in transfected human embryonic kidney (HEK)-293 cells.
Cell culture and transient transfection. HEK epithelial cell line HEK-293 (CRL-1573) (11) was used as a representative for nonmuscle cells, and mouse adult myoblast line C 2C12 (CRL-1772) (32) was used as representative for myocytes to test the cytotoxicity of TnT fragments. C 2C12 and HEK-293 cells were cultured in Dulbecco's modified eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 100 g/ml penicillin, and 50 g/ml streptomycin at 37°C in 5% CO 2. Transient transfection of C 2C12 and HEK-293 cells with purified pTracer plasmid DNA was carried out using two different protocols modified from the manufacturers' suggestions. HEK-293 cells were transfected with a 1.5:1 ratio (l/g) of HEKFectin (Bio-Rad): DNA per well of 24-well plate was seeded with 1.5 ϫ 10 5 cells the night before. HEKFectin and plasmid DNA were separately diluted in 25-l serum-free DMEM and combined after incubation at room temperature for 5 min. The HEKFectin/DNA complexes were incubated at room temperature for an additional 20 min before being added to the monolayer cells in 0.25 ml of serum-free DMEM. The media was replaced with DMEM supplemented with 10% FBS 6 h after the state of transfection.
C 2C12 cells were seeded at 0.5 ϫ 10 4 cells per well in 24-well plates 12 h before transfection, which gave a density of 40 -50% confluence. Cells were transfected with 2:1 ratio (l/g) mixture of LipofectAMINE 2000 (Invitrogen) and DNA. LipofectAMINE 2000 and DNA were diluted separately in 25 l of serum-free DMEM and preincubated at room temperature for 30 min before being combined and incubated at room temperature for an additional 20 min. The mixture was then added to C2C12 cells in 0.45 ml of serum-free DMEM. The media was replaced with DMEM supplemented with 10% FBS 24 h after the state of transfection.
Cultured for 30 -32 h after transfection, the cells were examined for the expression of GFP under an epifluorescence microscope (Zeiss Axiovert 100). Each experimental group was tested in triplicate.
MTT assay. MTT [3-(4, 5-dimethylthiazolyl-2l)-2, 5-diphenyl tetrazolium; Sigma] assay (8) was applied to examine the cytotoxicity of the TnT fragments in transfected cells. The yellow MTT salt is reduced by NADH and NADPH in metabolically active cells, resulting in intracellular formazan that can be solubilized and quantified by spectrophotometry with a linear relationship to the number of living cells. When apoptosis or necrosis reduces metabolic rate in the cell population, the reduction in cell viability can be sensitively detected by MTT assay.
An identical number of cells was seeded in each transfection and control wells. The transfected cells were washed twice with phosphate-buffered saline (PBS) before fresh complete culture media containing 0.5 mg/ml MTT was added. The cells were incubated at 37°C in 5% CO2 for 4 h. The culture media were then removed, and the cells were extracted for formazan with 300 l of solubilization buffer (10% SDS and 25% N,N-dimethylformamide) per well of 24-well plates, in the dark, with shaking for 30 min. Wells containing only media served as negative control. One hundred microliters of the supernatants were transferred to 96-well microtitering plate, and the absorbance at 595 nm was read with a microplate reader (Bio-Rad Benchmark). The results of cell viability were calculated as percentage of the control value of untransfected wells.
Propidium iodide staining and flow cytometry. The transfected cells were stained with propidium iodide (PI) using a published protocol (25) to identify late apoptotic or necrotic cells with increased membrane permissibility. Flow cytometry was employed to quantify the transfected GFP-positive cells, which are also PI positive, the cells were harvested rapidly by trypsinization, washed twice with PBS, and stained with 100 ng/ml PI in PBS at room temperature for 5 min. Flow cytometry analysis was carried out using a FACSCalibur flow cytometer (FACScan; Becton Dickinson Immunocytometry Systems, San Jose, CA). GFP fluorescence was detected by excitation at 488 nm and emission at 515-545 nm with the FL1 channel. PI fluorescence was detected by excitation at 493-536 nm and emission at 564 -606 nm with the FL3 channel. Background fluorescence of unstained nontransfected cells, transfected GFP-positive cells, or PI-stained nontransfected cells was used to set up gates and photomultiplier tube voltages and amperage gain for each channel. To exclude cell debris, cells were gated using standard forward and side scatter properties. Approximately 1 ϫ 10 4 viable cell events were acquired for each sample, and the data were analyzed using the FlowJo 7.2.5 software (TreeStar).
Cytoplasm-free nucleosome assay. To detect apoptosis, cytoplasmfree nucleosome assay was employed using a Cell Death Detection ELISA PLUS kit from Roche Applied Science. This enzyme-linked immunosorbent assay detects the release of free nucleosomes from nucleus to cytoplasm before disintegration of the plasma membrane, which is an established hallmark of apoptosis (13) .
The transfected cells were trypsinized and collected by centrifugation at 500 g for 15 min. The cells collected from each well of 24-well plates were lysed in 200 l of lysis buffer at room temperature for 30 min. The cell lysate was centrifuged at 500 g for 15 min to remove nuclei. The lysate supernatant was measured for protein concentration using Bradford reagent (Bio-Rad) (4). An aliquot containing 200-g proteins from each sample was added to a streptavidin-coated 96-well microplate. As described in the manufacturer's instruction, one-step sandwich ELISA was performed by adding biotin-labeled anti-histone and peroxidase-conjugated anti-DNA MAbs, and incubation occured at room temperature for 2 h. After being washed three times, H 2O2-ABTS [2,2Ј-azino-di(3-ethylbenzthiazoline-sulfonate)] substrate solution was added at 100 l/well and incubated at room temperature for 20 min. Dual absorbance at 405 nm-to-490 nm ratio was measured using an automated microplate reader (Bio-Rad Benchmark). The 405-nm-to-490-nm ratio absorbance values were normalized by the transfection rate. The results from cells transfected with different TnT fragments were compared with that of control cells to determine the relative level of apoptotic events in the cell population.
Statistical analysis. Data are presented as means Ϯ SE or SD, as noted in Fig. 3-6 legends. Statistically significant differences were established with two-tailed Student's t-test, in which P Ͻ 0.05 denotes a significant difference.
RESULTS

Engineering of representative fragments of TnT.
To investigate the cytotoxic effect of the established structure-function domains of TnT, we engineered intact TnT and four TnT fragments, representing the NH 2 -terminal variable region, the middle conserved region, the COOH-terminal conserved region, and a myopathic mutation containing the NH 2 -terminal and middle regions (Fig. 1) .
The middle and COOH-terminal regions of TnT are highly conserved among isoforms and across species, so the use of MsTnT 51met-154 and MsTnT-T2 fragments derived from mouse slow skeletal muscle TnT can serve as informative representatives. In contrast, the NH 2 -terminal region is hypervariable. We selected the NH 2 -terminal segment of HcTnT (HcTnT-N68) as a representative to test cytotoxicity, since it represents an NH 2 -terminal structure that is physiologically cleaved and released from the myofilaments under stress conditions (7, 33) . To examine the cytotoxic effect when the conserved and variable regions are resided in an intact TnT or large fragment, intact cardiac TnT (HcTnT) and COOH-terminal truncated slow TnT (MsTnT 1-179 ) were also studied.
Authenticity of the representative TnT fragments engineered was verified by expression in E. coli for SDS-PAGE and Western blotting examinations. Shown in Fig. 2 , the intact TnT and four TnT fragments had anticipated gel mobility in SDS-PAGE, consistent with the predicted molecular weights (Table  1) . Western blots using site-specific MAbs further confirmed that intact HcTnT and MsTnT 1-179 were identified by MAb CT3, the NH 2 -terminal fragment HcTnT-N68 was identified by MAb 3G7, the middle fragment MsTnT 51met-154 was identified by MAb 2C8, and the MsTnT-T2 fragment was identified by MAb 1G9.
Transient expression of TnT fragments resulted in cytotoxicity in myoblasts and nonmuscle cells. The efficiency of the transient transfections was first examined in culture plates using epifluorescence microscopy. The rates of transient transfection were further quantified using flow cytometry. The results in Fig. 3 showed that, despite the different expression constructs, an average of 54.6 Ϯ 4.0% of the transfected HEK-293 cells and 18.91 Ϯ 2.9% of the transfected C 2 C 12 cells expressed GFP, reflecting the proportion of cells contained the recombinant pTracer plasmids that bicistronically also express the TnT fragment (Fig. 1D) . C 2 C 12 cells showed a lower efficiency in transient transfection than that of HEK-293 cells in these experiments. However, the transfection rates were reproducibly over 15%, providing a reliable experimental condition for our study of the cytotoxicity of TnT fragments. According to Poisson distribution, the Ͻ63.2% transfection rates in our experiments would not produce a significant occurrence of cells transfected with more than one expression vector. Assuming that the GFP-positive cells each contain only one copy of the expression plasmid DNA, the expression of GFP and TnT by the bicistronic vector allowed us to use GFP expression as a direct and quantitative indicator for TnT expression.
We first evaluated the overall viability of the cells transfectively expressing each of the representative TnT fragments. By using MTT assay, we compared the proportion of viable cells at 30 h after the state of transfection with the different expression constructs. The results in Fig. 4 demonstrated that the , and MsTnT-ANM1-179 (E) were expressed in E. coli transformed with the recombinant pAED4 plasmid. Total protein extracts were resolved on SDS-PAGE, and Western blotting was performed using region-specific anti-TnT monoclonal antibodies (MAbs) to verify the TnT protein expressed. Total protein extracts from anonymous human left ventricular muscle and adult mouse soleus muscle were used as controls. The unusually faster gel mobility of HcTnT-N68 may be due to its highly negative charge (Table 1) . MW, molecular weight. (Fig. 4) . These results indicate significant cytotoxicity of the middle and COOH-terminal regions of TnT.
MTT assay detected that the expression of intact HcTnT had a moderate but statistically significant cytotoxicity in HEK-293 cells (22.9 Ϯ 2.6%), but not in C 2 C 12 cells (12.5 Ϯ 0.8%). The expression of MsTnT 1-179 also showed intermediate cytotoxicities in both cell types (18.4 Ϯ 8.1% in HEK-293 cells and 17.9 Ϯ 2.3% in C 2 C 12 cells) (Fig. 4) .
Transfective expression of TnT fragments in the absence of myofilaments resulted in cell death. To further investigate the cytotoxicity of TnT fragments, PI staining detected necrotic or late apoptotic cells in HEK-293 and C 2 C 12 cultures transfectively expressing the representative TnT fragments. The flow cytometry data in Fig. 5 showed that the transfection of recombinant plasmid expressing the NH 2 -terminal fragment of TnT (HcTnT-N68) did not increase the PI-positive population among the GFP-positive cells compared with the vector-transfected control. However, significantly higher numbers of GFP-PI double-positive cells were detected in HEK-293 and C 2 C 12 cultures transfectively expressing the middle (MsTnT 51met-154 ) or COOH-terminal (MsTnT-T2) fragment of TnT. The results confirmed that, when expressed in the absence of myofilaments, the middle and COOH-terminal regions, but not the NH 2 -terminal region, of TnT have cytotoxicity and result in cell death. Similar to that in MTT assays, intact HcTnT and MsTnT 1-179 resulted in intermediate cytotoxicity in both cell types (Fig. 5) .
Transfective expression of the middle and COOH-terminal fragments of TnT-induced apoptosis. The cytotoxic effect of TnT fragments on inducing apoptosis was studied using cytoplasm free nucleosome assay that detects chromosomal DNA fragments released to the cytoplasm to identify DNA breaks, an established feature of early apoptotic cells before the loss of DNA contents or morphological variations. Consistent with the results of MTT assay and PI staining, the data in Fig. 6 showed significant increases in early apoptotic cells in HEK-293 and C 2 C 12 cultures transfectively expressing the middle or COOHterminal fragment, but not that expressing the NH 2 -terminal fragment, of TnT. These results indicate that the cytotoxicity of the middle and COOH-terminal fragments of TnT is through inducing apoptosis other than direct necrotic effects.
Different from the moderate rates of late apoptotic and dead cells by MTT assay (Fig. 4) and PI staining (Fig. 5) , intact HcTnT and MsTnT 1-179 produced remarkable increases in early apoptotic cells in HEK-293 and C 2 C 12 cultures.
DISCUSSION
TnT is a muscle-specific protein and expresses in differentiated muscle cells as a major component of the myofilaments (27) . Our laboratory previously observed that muscle cells have a high capacity of degrading nonmyofilament-incorporated TnT (31) . Implied by the difficulty in establishing stable transfected cell lines expressing TnT or TnT fragments in the absence of myofilaments (unpublished results), a hypothesis was proposed that a significant level of nonmyofilamentassociated TnT or TnT fragments may be harmful to the myocyte.
The present study investigated the potential cytotoxicity of TnT in mammalian cells. Using three independent assays (MTT analysis, PI staining, and detection of free nucleosomes) to examine cell viability, cell death, and apoptosis, the results clearly demonstrated apoptosis-based cytotoxicity of the mid- dle and COOH-terminal fragments of TnT. The middle and COOH-terminal regions are highly conserved among the three muscle-type isoforms of TnT and across species (18) . Therefore, their cytotoxicity demonstrated using constructs derived from slow skeletal muscle TnT represents a common feature of these regions of the TnT polypeptide. The middle and COOHterminal regions of TnT contain binding sites for TnI, TnC, and tropomyosin, and it is plausible that they are normally integrated in the thin-filament protein complex, which would preventing the free structure-based cytotoxicity.
In contrast, the NH 2 -terminal variable region of TnT did not show any cytotoxicity when transfectively expressed in cells in the absence of myofilament. The NH 2 -terminal variable region of TnT does not bind any known thin-filament proteins. It can be cleaved off by restricted proteolysis as a physiological adaptation to stress conditions, leaving the conserved middle and COOH-terminal regions integrated in the myofilaments (7, 33) . These structural and functional features are consistent with the fact that the NH 2 -terminal fragment of TnT is nontoxic, as its acute release from the myofilament may occur in large quantities as a physiological adaptation to stress conditions (33) , although subsequent decomposition of the myofilament in severe ischemia-reperfusion injuries may release the middle and COOH-terminal regions of TnT to cause cytotoxicity.
Intact cardiac TnT containing all three regions and a COOHterminal truncated slow TnT found in a recessively inherited nemaline myopathy (15) , which fails to incorporate into myofilaments due to much weakened binding to tropomyosin (31) , exhibited intermediate cytotoxicities in cells lacking myofilaments. These results suggest that the combination with the NH 2 -terminal segment may reduce the toxicity of the middle and COOH-terminal regions. A more native folding of intact TnT and larger fragments may also play a role in this reduced cytotoxicity.
A trend seen in the cytotoxicity experiments was that transfective expression of middle or COOH-terminal fragment of TnT had more predominant cytotoxicity in C 2 C 12 myoblasts than that in HEK-293 nonmuscle cells (Figs. 4 -6) , although the transfection rates were lower for C 2 C 12 cells than for HEK-293 cells (Fig. 3) . A possible explanation is that the cellular environment in myoblasts has evolved for rapid synthesis of myofilament proteins, and, therefore, the transfective expression of TnT might be more effective in C 2 C 12 cells than in HEK-293 epithelial cells.
The finding that nonmyofilament-associated TnT fragments induce apoptosis is of particular importance in cardiomyocytes. Adult cardiomyocytes of higher vertebrates are terminally differentiated cells that cannot regenerate. Therefore, acute or chronic death of myocytes in adult hearts would reduce the number of cardiac muscle cells and eventually cause heart failure. Apoptosis of cardiomyocytes is responsible for the progression of many cardiovascular disorders, including acute myocardial infarction and chronic ischemic cardiomyopathy (22, 28) . These conditions involve significant myofilament decomposition or remodeling, in which TnT is released with a potential cytotoxic effect. On the other hand, TnT was found to cross-link in human apoptotic cardiomyocytes (10) , which may prevent effective degradation and increase the likelihood to result in cytotoxicity. Therefore, the role of myofilamentreleased TnT or TnT fragments in triggering cell death in ischemic heart disease is worth further investigation.
Numerous studies have investigated the pathways that regulate cardiomyocyte apoptosis (29) . Caspases are commonly occurring mediators of apoptosis and are induced and activated in cardiomyopathy (24) . Caspase-3 was found to cleave cardiac TnT in the middle region between Asp 96 and Asp 97 in myocardial ischemia-reperfusion injury (5). We further demonstrated that this truncation reduces the binding affinity of cardiac TnT for tropomyosin (2) . Therefore, the cleavage of cardiac TnT by caspase-3 not only impairs myocardial contractility (5) but also favors a dissociation of the toxic middle and COOH-terminal portions of cardiac TnT from the myofilaments to result in cytotoxicity. It would be interesting to investigate whether this fragmentation of cardiac TnT contributes to the apoptotic cascade downstream of the caspase cell signaling pathway.
There have been other suggestions for the involvement of nonmyofilament-associated TnT in inducing apoptotic cell death. Overexpression of muscleblind protein activates apoptotic cell death. Recent studies found that the splicing of TnT mRNA was affected by the muscleblind proteins in Drosophila (30) and in mammalian cells (12) . Therefore, it is worth investigating whether the apoptosis signaling of muscleblind protein involves aberrantly spliced TnT polypeptides that are incapable of incorporating into myofilaments and result in cytotoxicity and cell death. There is also evidence from nonmuscle cell studies to support the hypothesis that nonmyofilament-associated TnT may cause cell death. A microarray study found that the expression of slow skeletal muscle TnT in mouse brain was induced by ketamine, a noncompetitive glutamate N-methyl-D-aspartic acid receptor antagonist that has paradoxical effects on neuroprotection and neurotoxicity (20) . Proteins immunologically cross-reactive with TnT have been observed in diverse types of nonmuscle cells from the animal, plant, and fungal kingdoms (19) . Immunofluorescence microscopy and immunoblot analyses using a MAb generated against TnT found microtubule-associated and nonmicrotubule-associated TnT-like components in nonmuscle tissues, such as brain and cerebellar homogenates. Besides a possible role in Ca 2ϩ or calmodulin-related cellular activities, the TnTlike proteins may have a function in regulating programmed cell death, which is worth further investigation.
In summary, we have demonstrated novel evidence that nonmyofilament-associated TnT and fragments containing the middle and COOH-terminal regions are able to induce apoptosis. For its abundant presence in the myofilaments, peak release of TnT and TnT fragments in myocardial injuries exceeding the capacity of proteolytic degradation would result in the death of myocytes. While the mechanism by which TnT fragments cause cytotoxicity remains to be established, the potential contribution of this mechanism to acute and chronic losses of adult cardiomyocytes and the development of heart failure merit further investigation.
